tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR-IPR-17011233】對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

    基本信息
    登记号

    ChiCTR-IPR-17011233

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2017-04-24

    临床申请受理号

    /

    靶点

    /

    适应症

    Autism Spectrum Disorder

    试验通俗题目

    對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

    试验专业题目

    對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    The goals of this project are to 1) reduce public stigma towards people and families with ASD and to improve the wellbeing of people and families with ASD in Hong Kong; 2) to evaluate the acceptability and effectiveness of a mindfulness training programme for adolescents with ASD and their parents for the first time in Hong Kong. The objectives of this project are to: 1) improve public awareness of ASD in Hong Kong 2) improve social responsiveness and reduce problem behaviours of adolescents with ASD 3) reduce parental stress and improve parenting style of parents of adolescents with ASD 4) develop and improve the expertise of health professionals in providing mindfulness interventions for adolescents with ASD.

    试验分类
    试验类型

    随机平行对照

    试验分期

    探索性研究/预试验

    随机化

    After the baseline visit, participants will be randomly assigned to one of the treatment groups by using a list of computer-generated random numbers. This generation of random numbers and assignment will be performed by an independent statistician.

    盲法

    The participants and instructors by nature will be informed of the randomisation allocation results, however, the trained research assistant/associate who conducts the assessments and the statistician who conducts the data analysis will be kept blinded of the grouping.

    试验项目经费来源

    FOOD AND HEALTH BUREAU, HONG KONG SAR

    试验范围

    /

    目标入组人数

    16

    实际入组人数

    /

    第一例入组时间

    2017-07-05

    试验终止时间

    2018-07-04

    是否属于一致性

    /

    入选标准

    The inclusion criteria of participants for the training will be children aged 12 to 18 years who have received a diagnosis of Autism Spectrum Disorders (ASD) by a doctor and also one of their parents agrees to participate in the MYmind training. Furthermore, if the child is on medication for ASD, the parents should have confirmed that they do not intend to change the medication status of their child during the study period. Parents will be asked to bring a copy of the ASD diagnosis of their children from a clinical doctor, usually a psychiatrist, for confirmation of the ASD diagnosis during the interview before they attend the MYmind training programme.；

    排除标准

    The exclusion criteria will be: 1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; 2)having a medical condition rendering him/her to be incapable to participate in the study; 3) unwilling or unable to give consent; 4) having substance dependence within the past 6 months, or a history of mental retardation, borderline and antisocial personality disorder, chronic suicidal and self-injurious behavior; or 5) participating in another ongoing psychological intervention.；

    研究者信息
    研究负责人姓名
    试验机构

    HEALTH CARE AND PROMOTION FUND

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    HEALTH CARE AND PROMOTION FUND的其他临床试验

    更多

    最新临床资讯

    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品